tm logo
BISCENDO
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 04 Jul 2022

Last Applicant/ Owned by

One Amgen Center Drive

Thousand Oaks

CA

913201799

Serial Number

88783519 filed on 03rd Feb 2020

Registration Number

N/A

Correspondent Address

Timothy J. Gaul

AMGEN INC.

TRADEMARK OPERATIONS - MS-28-5A

ONE AMGEN CENTER DRIVE

THOUSAND OAKS CA 91320-1799

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

BISCENDO

pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, inflammation, inflammatory diseases and disorders, neurological diseases and disorders and metabolic diseases and disorders

Mark Details


Serial Number

No 88783519

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-2051-US-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Jul 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
04th Jul 2022ABANDONMENT - NO USE STATEMENT FILED
18th Sep 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Sep 2021SOU TEAS EXTENSION RECEIVED
16th Sep 2021SOU EXTENSION 2 FILED
16th Sep 2021SOU EXTENSION 2 GRANTED
06th May 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04th May 2021SOU TEAS EXTENSION RECEIVED
04th May 2021SOU EXTENSION 1 FILED
04th May 2021SOU EXTENSION 1 GRANTED